Evaluating the safety of interventions for prevention of perinatal transmission of HIV.
- 25 January 2006
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 918 (1), 201-211
- https://doi.org/10.1111/j.1749-6632.2000.tb05490.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analoguesThe Lancet, 1999
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineNew England Journal of Medicine, 1996
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- Treatment of Wilms' tumor. Results of the third national Wilms' tumor studyCancer, 1989